1 / 5

Impact of Testosterone Utilization Changes after UF/PA Decisions

This study analyzes the defensive health agency's utilization changes after UF/PA decisions on Testosterone-30 DE across different sources from June 2012 to July 2013. Gain insights into the effects of policy shifts on Testosterone therapy.

lynde
Télécharger la présentation

Impact of Testosterone Utilization Changes after UF/PA Decisions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Defense Health Agency Utilization Changes AfterUF/PA DecisionsTestosterone

  2. Testosterone 30 DE, All POS Source: PDTS, June 2012 – Jul 2013

  3. Testosterone 30 DE, Retail Source: PDTS, June 2012 – Jul 2013

  4. Testosterone 30 DE, Mail Source: PDTS, June 2012 – Jul 2013

  5. Testosterone 30 DE, MTF Source: PDTS, June 2012 – Jul 2013

More Related